“SECOND-GENERATION TYROSINE KINASE INHIBITORS (TKI) AS SALVAGE THERAPY FOR RESISTANT OR INTOLERANT PATIENTS TO PRIOR TKIs” (2014) Mediterranean Journal of Hematology and Infectious Diseases, 6(1), p. e2014003. doi:10.4084/mjhid.2014.003.